Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kim, CJ; Chang, YK; Chun, GT; Jeong, YH; Lee, SJ
   Continuous culture of immobilized Streptomyces cells for kasugamycin production
   BIOTECHNOLOGY PROGRESS
   
   C.J. Kim et al., "Continuous culture of immobilized Streptomyces cells for kasugamycin production", BIOTECH PR, 17(3), 2001, pp. 453-461
2. Goodman, GR; Dissanayake, IR; Bowman, AR; Pun, S; Ma, Y; Jee, WSS; Bryer, HP; Epstein, S
   Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss
   BONE
   
   G.R. Goodman et al., "Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss", BONE, 28(6), 2001, pp. 583-588
3. Ranganathan, SC; Payne, DNR; Jaffe, A; McKenzie, SA
   Difficult asthma: Defining the problems
   PEDIATRIC PULMONOLOGY
   
   S.C. Ranganathan et al., "Difficult asthma: Defining the problems", PEDIAT PULM, 31(2), 2001, pp. 114-120
4. Dowling, PM
   Options for treating feline asthma
   VETERINARY MEDICINE
   
   P.M. Dowling, "Options for treating feline asthma", VET MED-US, 96(5), 2001, pp. 353-356
5. Trobonjaca, Z; Radosevic-Stasic, B; Crncevic, Z; Rukavina, D
   Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   Z. Trobonjaca et al., "Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes", INT IMMUNO, 1(9-10), 2001, pp. 1753-1764
6. Mosca, M; Ruiz-Irastorza, G; Khamashta, MA; Hughes, GRV
   Treatment of systemic lupus erythematosus
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   M. Mosca et al., "Treatment of systemic lupus erythematosus", INT IMMUNO, 1(6), 2001, pp. 1065-1075
7. Sakuma, S; Higashi, Y; Sato, N; Sasakawa, T; Sengoku, T; Ohkubo, Y; Amaya, T; Goto, T
   Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids)
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   S. Sakuma et al., "Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids)", INT IMMUNO, 1(6), 2001, pp. 1219-1226
8. Szebeni, J; Alving, CR; Savay, S; Barenholz, Y; Priev, A; Danino, D; Talmon, Y
   Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   J. Szebeni et al., "Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions", INT IMMUNO, 1(4), 2001, pp. 721-735
9. Fujino, M; Li, XK; Guo, L; Amano, T; Suzuki, S
   Activation of caspases and mitochondria in FTY720-mediated apoptosis in human T cell line Jurkat
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   M. Fujino et al., "Activation of caspases and mitochondria in FTY720-mediated apoptosis in human T cell line Jurkat", INT IMMUNO, 1(11), 2001, pp. 2011-2021
10. Esquifino, AI; Castrillon, PO; Arce, A; Cutrera, RA; Cardinali, DP
    Effect of parasympathetic decentralization on interferon-gamma release from rat submandibular lymph nodes in vitro
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    
    A.I. Esquifino et al., "Effect of parasympathetic decentralization on interferon-gamma release from rat submandibular lymph nodes in vitro", AUTON NEURO, 91(1-2), 2001, pp. 10-15
11. Duvilanski, BH; Castrillon, PO; Cano, P; Velardez, MO; Esquifino, AI
    Changes in substance P content at the hypothalamic-pituitary axis during the Wallerian degeneration of peripheral sympathetic neurons after superior cervical ganglionectomy in male rats: Effect of hyperprolactinemia
    EXPERIMENTAL BIOLOGY AND MEDICINE
    
    B.H. Duvilanski et al., "Changes in substance P content at the hypothalamic-pituitary axis during the Wallerian degeneration of peripheral sympathetic neurons after superior cervical ganglionectomy in male rats: Effect of hyperprolactinemia", EXP BIOL ME, 226(6), 2001, pp. 612-617
12. Eason, JD; Loss, GE; Blazek, J; Nair, S; Mason, AL
    Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial
    LIVER TRANSPLANTATION
    
    J.D. Eason et al., "Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial", LIVER TRANS, 7(8), 2001, pp. 693-697
13. Kneteman, NM
    Steroid-free immunosuppression: Balancing efficacy and toxicity
    LIVER TRANSPLANTATION
    
    N.M. Kneteman, "Steroid-free immunosuppression: Balancing efficacy and toxicity", LIVER TRANS, 7(8), 2001, pp. 698-700
14. McAlister, VC; Peltekian, KM; Malatjalian, DA; Colohan, S; MacDonald, S; Bitter-Suermann, H; MacDonald, AS
    Orthotopic liver transplantation using low-dose tacrolimus and sirolimus
    LIVER TRANSPLANTATION
    
    V.C. McAlister et al., "Orthotopic liver transplantation using low-dose tacrolimus and sirolimus", LIVER TRANS, 7(8), 2001, pp. 701-708
15. Jain, A; Demetris, AJ; Kashyap, R; Blakomer, K; Ruppert, K; Khan, A; Rohal, S; Starzl, TE; Fung, JJ
    Does tacrolimus offer virtual freedom from chronic rejection after primaryliver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years
    LIVER TRANSPLANTATION
    
    A. Jain et al., "Does tacrolimus offer virtual freedom from chronic rejection after primaryliver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years", LIVER TRANS, 7(7), 2001, pp. 623-630
16. Hughes, VF; Melvin, DG; Niranjan, M; Alexander, GAM; Trull, AK
    Clinical validation of an artificial neural network trained to identify acute allograft rejection in liver transplant recipients
    LIVER TRANSPLANTATION
    
    V.F. Hughes et al., "Clinical validation of an artificial neural network trained to identify acute allograft rejection in liver transplant recipients", LIVER TRANS, 7(6), 2001, pp. 496-503
17. Trotter, JF; Wachs, M; Bak, T; Trouillot, T; Stolpman, N; Everson, GT; Kam, I
    Liver transplantation using sirolimus and minimal corticosteroids (3-day taper)
    LIVER TRANSPLANTATION
    
    J.F. Trotter et al., "Liver transplantation using sirolimus and minimal corticosteroids (3-day taper)", LIVER TRANS, 7(4), 2001, pp. 343-351
18. Emre, S; Gondolesi, G; Polat, K; Ben-Haim, M; Artis, T; Fishbein, TM; Sheiner, PA; Kim-Schluger, L; Schwartz, ME; Miller, CM
    Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function
    LIVER TRANSPLANTATION
    
    S. Emre et al., "Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function", LIVER TRANS, 7(3), 2001, pp. 220-225
19. Honore, P; Detry, O; Hamoir, E; Defechereux, T; Detroz, B; Meurisse, M; Jacquet, N
    Right hepatic lobectomy as a liver graft-saving procedure
    LIVER TRANSPLANTATION
    
    P. Honore et al., "Right hepatic lobectomy as a liver graft-saving procedure", LIVER TRANS, 7(3), 2001, pp. 269-273
20. Manzarbeitia, C; Reich, DJ; Rothstein, KD; Braitman, LE; Levin, S; Munoz, SJ
    Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients
    LIVER TRANSPLANTATION
    
    C. Manzarbeitia et al., "Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients", LIVER TRANS, 7(2), 2001, pp. 93-99
21. Reuben, A
    Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity
    LIVER TRANSPLANTATION
    
    A. Reuben, "Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity", LIVER TRANS, 7(11), 2001, pp. S13-S21
22. Gonwa, TA
    Hypertension and renal dysfunction in long-term liver transplant recipients
    LIVER TRANSPLANTATION
    
    T.A. Gonwa, "Hypertension and renal dysfunction in long-term liver transplant recipients", LIVER TRANS, 7(11), 2001, pp. S22-S26
23. Beresford, TP
    Neuropsychiatric complications of liver and other solid organ transplantation
    LIVER TRANSPLANTATION
    
    T.P. Beresford, "Neuropsychiatric complications of liver and other solid organ transplantation", LIVER TRANS, 7(11), 2001, pp. S36-S45
24. Levy, GA
    Long-term immunosuppression and drug interactions
    LIVER TRANSPLANTATION
    
    G.A. Levy, "Long-term immunosuppression and drug interactions", LIVER TRANS, 7(11), 2001, pp. S53-S59
25. Fung, JJ; Jain, A; Kwak, EJ; Kusne, S; Dvorchik, I; Eghtesad, B
    De novo malignancies after liver transplantation: A major cause of late death
    LIVER TRANSPLANTATION
    
    J.J. Fung et al., "De novo malignancies after liver transplantation: A major cause of late death", LIVER TRANS, 7(11), 2001, pp. S109-S118
26. Wijdicks, EFM
    Neurotoxicity of immunosuppressive drugs
    LIVER TRANSPLANTATION
    
    E.F.M. Wijdicks, "Neurotoxicity of immunosuppressive drugs", LIVER TRANS, 7(11), 2001, pp. 937-942
27. Baron, PW; Heneghan, MA; Suhocki, PV; Nuckols, JD; Tuttle-Newhall, JE; Howell, DN; Clavien, PA
    Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation
    LIVER TRANSPLANTATION
    
    P.W. Baron et al., "Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation", LIVER TRANS, 7(1), 2001, pp. 62-67
28. Nagler, A; Menachem, Y; Ilan, Y
    Amelioration of steroid-resistant chronic graft-versus-host-mediated liverdisease via tacrolimus treatment
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    A. Nagler et al., "Amelioration of steroid-resistant chronic graft-versus-host-mediated liverdisease via tacrolimus treatment", J HEMATH ST, 10(3), 2001, pp. 411-417
29. Pincus, T; Sokka, T
    How can the risk of long-term consequences of rheumatoid arthritis be reduced?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    T. Pincus e T. Sokka, "How can the risk of long-term consequences of rheumatoid arthritis be reduced?", BEST PR R C, 15(1), 2001, pp. 139-170
30. Tassignon, J; Vandevelde, M; Goldman, M
    Azodicarbonamide as a new T cell immunosuppressant: Synergy with cyclosporin A
    CLINICAL IMMUNOLOGY
    
    J. Tassignon et al., "Azodicarbonamide as a new T cell immunosuppressant: Synergy with cyclosporin A", CLIN IMMUNO, 100(1), 2001, pp. 24-30
31. Chehimi, J; Elder, M; Greene, J; Noroski, L; Stiehm, ER; Winkelstein, JA; Sullivan, KE
    Cytokine and chemokine dysregulation in hyper-IgE syndrome
    CLINICAL IMMUNOLOGY
    
    J. Chehimi et al., "Cytokine and chemokine dysregulation in hyper-IgE syndrome", CLIN IMMUNO, 100(1), 2001, pp. 49-56
32. Chen, WR; Thoburn, CJ; Miura, Y; Sommer, M; Hruban, R; Qian, ZP; Baldwin, W; Hess, AD
    Autoimmune-mediated vasculopathy
    CLINICAL IMMUNOLOGY
    
    W.R. Chen et al., "Autoimmune-mediated vasculopathy", CLIN IMMUNO, 100(1), 2001, pp. 57-70
33. Kumar, MT; Pandit, JK; Balasubramaniam, J
    Novel therapeutic approaches for uveitis and retinitis
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
    
    M.T. Kumar et al., "Novel therapeutic approaches for uveitis and retinitis", J PHARM P S, 4(3), 2001, pp. 248-254
34. Brenner, BG; Wainberg, Z
    Heat shock proteins: novel therapeutic tools for HIV-infection?
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    B.G. Brenner e Z. Wainberg, "Heat shock proteins: novel therapeutic tools for HIV-infection?", EXPERT OP B, 1(1), 2001, pp. 67-77
35. Wang, P; Cardenas, ME; Cox, CM; Perfect, JR; Heitman, J
    Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans
    EMBO REPORTS
    
    P. Wang et al., "Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans", EMBO REP, 2(6), 2001, pp. 511-518
36. Patel, S; Veale, D; FitzGerald, O; McHugh, NJ
    Psoriatic arthritis - emerging concepts
    RHEUMATOLOGY
    
    S. Patel et al., "Psoriatic arthritis - emerging concepts", RHEUMATOLOG, 40(3), 2001, pp. 243-246
37. Quinn, MA; Conaghan, PG; Emery, P
    The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?
    RHEUMATOLOGY
    
    M.A. Quinn et al., "The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?", RHEUMATOLOG, 40(11), 2001, pp. 1211-1220
38. Stephan, JL; Kone-Paut, I; Galambrun, C; Mouy, R; Bader-Meunier, B; Prieur, AM
    Reactive haemophagocytic syndrome in children with inflammatory disorders.A retrospective study of 24 patients
    RHEUMATOLOGY
    
    J.L. Stephan et al., "Reactive haemophagocytic syndrome in children with inflammatory disorders.A retrospective study of 24 patients", RHEUMATOLOG, 40(11), 2001, pp. 1285-1292
39. Hatrick, NC; Tonkin, MA
    Hand transplantation: A current perspective
    ANZ journal of surgery
    
    N.C. Hatrick e M.A. Tonkin, "Hand transplantation: A current perspective", AUST NZ J S, 71(4), 2001, pp. 245-251
40. Ambach, A; Bonnekoh, B; Gollnick, H
    Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin but not by methotrexate
    SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    
    A. Ambach et al., "Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin but not by methotrexate", SKIN PH APP, 14(5), 2001, pp. 249-260
41. van de Kerkhof, PCM
    New developments in the treatment of psoriasis
    SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    
    P.C.M. van de Kerkhof, "New developments in the treatment of psoriasis", SKIN PH APP, 14(3), 2001, pp. 129-135
42. Keller, TH; Hersperger, R; Della Cioppa, G
    Macrocyclic immunosuppressants
    NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    
    T.H. Keller et al., "Macrocyclic immunosuppressants", PROG R RES, 31, 2001, pp. 237-240
43. Van Regenmortel, MHV
    Analysing structure-function relationships with biosensors
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    M.H.V. Van Regenmortel, "Analysing structure-function relationships with biosensors", CELL MOL L, 58(5-6), 2001, pp. 794-800
44. Gossmann, J; Radounikli, A; Bernemann, A; Schellinski, O; Raab, HP; Bickeboller, R; Scheuermann, EH
    Pathophysiology of cyclosporine-induced nephrotoxicity in humans: A role for nitric oxide?
    KIDNEY & BLOOD PRESSURE RESEARCH
    
    J. Gossmann et al., "Pathophysiology of cyclosporine-induced nephrotoxicity in humans: A role for nitric oxide?", KIDNEY BL P, 24(2), 2001, pp. 111-115
45. Cochat, P; Ranchin, B
    Is there a need for a multicenter study to determine the optimal approach to recurrent nephrotic syndrome following renal transplantation?
    PEDIATRIC TRANSPLANTATION
    
    P. Cochat e B. Ranchin, "Is there a need for a multicenter study to determine the optimal approach to recurrent nephrotic syndrome following renal transplantation?", PEDIAT TRAN, 5(6), 2001, pp. 394-397
46. Flynn, JT; Bunchman, TE; Sherbotie, JR
    Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation
    PEDIATRIC TRANSPLANTATION
    
    J.T. Flynn et al., "Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation", PEDIAT TRAN, 5(6), 2001, pp. 439-446
47. Vanrenterghem, YFC
    Tailoring immunosuppressive therapy for renal transplant recipients
    PEDIATRIC TRANSPLANTATION
    
    Y.F.C. Vanrenterghem, "Tailoring immunosuppressive therapy for renal transplant recipients", PEDIAT TRAN, 5(6), 2001, pp. 467-472
48. Cacciarelli, TV; Reyes, J; Jaffe, R; Mazariegos, GV; Jain, A; Fung, JJ; Green, M
    Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients
    PEDIATRIC TRANSPLANTATION
    
    T.V. Cacciarelli et al., "Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients", PEDIAT TRAN, 5(5), 2001, pp. 359-364
49. Papalois, VE; Najarian, JS
    Pediatric kidney transplantation: Historic hallmarks and a personal perspective
    PEDIATRIC TRANSPLANTATION
    
    V.E. Papalois e J.S. Najarian, "Pediatric kidney transplantation: Historic hallmarks and a personal perspective", PEDIAT TRAN, 5(4), 2001, pp. 239-245
50. Collins, MH; Montone, KT; Leahey, AM; Hodinka, RL; Salhany, KE; Kramer, DL; Deng, C; Tomaszewski, JR
    Post-transplant lymphoproliferative disease in children
    PEDIATRIC TRANSPLANTATION
    
    M.H. Collins et al., "Post-transplant lymphoproliferative disease in children", PEDIAT TRAN, 5(4), 2001, pp. 250-257
51. Hromadnikova, I; Sedlacek, P; Stary, J; Cermakova, M; Vavrinec, J; Stechova, K; Dolezalova, L; Sviland, L; Dickinson, AM
    An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants
    PEDIATRIC TRANSPLANTATION
    
    I. Hromadnikova et al., "An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants", PEDIAT TRAN, 5(4), 2001, pp. 258-265
52. Remberger, M; Mattsson, J; Ringden, O
    Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation
    PEDIATRIC TRANSPLANTATION
    
    M. Remberger et al., "Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation", PEDIAT TRAN, 5(4), 2001, pp. 285-292
53. Hasegawa, T; Nara, K; Kimura, T; Soh, H; Sasaki, T; Azuma, T; Okada, A
    Oral administration of tacrolimus in the presence of jejunostomy after liver transplantation
    PEDIATRIC TRANSPLANTATION
    
    T. Hasegawa et al., "Oral administration of tacrolimus in the presence of jejunostomy after liver transplantation", PEDIAT TRAN, 5(3), 2001, pp. 204-209
54. Mittal, N; Thompson, JF; Kato, T; Tzakis, AG
    Tacrolimus and diarrhea: Pathogenesis of altered metabolism
    PEDIATRIC TRANSPLANTATION
    
    N. Mittal et al., "Tacrolimus and diarrhea: Pathogenesis of altered metabolism", PEDIAT TRAN, 5(2), 2001, pp. 75-79
55. Jain, A; Mazariegos, G; Kashyap, R; Marsh, W; Khanna, A; Iurlano, K; Fung, J; Reyes, J
    Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation
    PEDIATRIC TRANSPLANTATION
    
    A. Jain et al., "Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation", PEDIAT TRAN, 5(2), 2001, pp. 93-98
56. Schell, M; Lachaux, A; Hadj-Aissa, A; Dubourg, L; Mahmoud, A; Boillot, O; Said, MH; Cochat, P
    Fading renal hyperfiltration in children following liver transplantation
    PEDIATRIC TRANSPLANTATION
    
    M. Schell et al., "Fading renal hyperfiltration in children following liver transplantation", PEDIAT TRAN, 5(1), 2001, pp. 51-55
57. Sedmera, P; Jegorov, A; Buchta, M; Cvak, L
    11-Demethylcyclosporins exhibit a single conformation in methanol and dimethylsulfoxide
    JOURNAL OF PEPTIDE RESEARCH
    
    P. Sedmera et al., "11-Demethylcyclosporins exhibit a single conformation in methanol and dimethylsulfoxide", J PEPT RES, 58(3), 2001, pp. 229-236
58. Schaufelberger, M; Eriksson, BO; Lonn, L; Rundqvist, B; Sunnerhagen, KS; Swedberg, K
    Skeletal muscle characteristics, muscle strength and thigh muscle area in patients before and after cardiac transplantation
    EUROPEAN JOURNAL OF HEART FAILURE
    
    M. Schaufelberger et al., "Skeletal muscle characteristics, muscle strength and thigh muscle area in patients before and after cardiac transplantation", EUR J HE FA, 3(1), 2001, pp. 59-67
59. Van Regenmortel, MHV; Choulier, L
    Recognition of peptides by antibodies and investigations of affinity usingbiosensor technology
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    
    M.H.V. Van Regenmortel e L. Choulier, "Recognition of peptides by antibodies and investigations of affinity usingbiosensor technology", COMB CHEM H, 4(5), 2001, pp. 385-395
60. Wouters, J; Ooms, F
    Small molecule crystallography in drug design
    CURRENT PHARMACEUTICAL DESIGN
    
    J. Wouters e F. Ooms, "Small molecule crystallography in drug design", CUR PHARM D, 7(7), 2001, pp. 529-545
61. Clausen, T; Bullock, R
    Medical treatment and neuroprotection in traumatic brain injury
    CURRENT PHARMACEUTICAL DESIGN
    
    T. Clausen e R. Bullock, "Medical treatment and neuroprotection in traumatic brain injury", CUR PHARM D, 7(15), 2001, pp. 1517-1532
62. Kusuhara, H; Sugiyama, Y
    Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1)
    DRUG DISCOVERY TODAY
    
    H. Kusuhara e Y. Sugiyama, "Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1)", DRUG DISC T, 6(3), 2001, pp. 150-156
63. Brinkmann, U; Roots, I; Eichelbaum, M
    Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy
    DRUG DISCOVERY TODAY
    
    U. Brinkmann et al., "Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy", DRUG DISC T, 6(16), 2001, pp. 835-839
64. Bobadilla, I; Franco, M; Cruz, D; Zamora, J; Robles, SG; Chavez, E
    Hypothyroidism provides resistance to reperfusion injury following myocardium ischemia
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    
    I. Bobadilla et al., "Hypothyroidism provides resistance to reperfusion injury following myocardium ischemia", INT J BIO C, 33(5), 2001, pp. 499-506
65. Tanabe, O; Hirata, D; Usui, H; Nishito, Y; Miyakawa, T; Igarashi, K; Takeda, M
    Fission yeast homologues of the B ' subunit of protein phosphatase 2A: multiple roles in mitotic cell division and functional interaction with calcineurin
    GENES TO CELLS
    
    O. Tanabe et al., "Fission yeast homologues of the B ' subunit of protein phosphatase 2A: multiple roles in mitotic cell division and functional interaction with calcineurin", GENES CELLS, 6(5), 2001, pp. 455-473
66. Mark, PJ; Ward, BK; Kumar, P; Lahooti, H; Minchin, RF; Ratajczak, T
    Human cyclophilin 40 is a heat shock protein that exhibits altered intracellular localization following heat shock
    CELL STRESS & CHAPERONES
    
    P.J. Mark et al., "Human cyclophilin 40 is a heat shock protein that exhibits altered intracellular localization following heat shock", CELL STR CH, 6(1), 2001, pp. 59-70
67. Fam, AG
    Recent advances in the management of adult myositis
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    A.G. Fam, "Recent advances in the management of adult myositis", EXPERT OP I, 10(7), 2001, pp. 1265-1277
68. Larner, AJ; Williamson, C; Ward, NS; Acheson, JF; Robinson, S; Farmer, SF
    Isolated familial hypomagnesaemia with novel neurological features: causallink or chance concurrence?
    EUROPEAN JOURNAL OF NEUROLOGY
    
    A.J. Larner et al., "Isolated familial hypomagnesaemia with novel neurological features: causallink or chance concurrence?", EUR J NEUR, 8(5), 2001, pp. 495-499
69. Holdaas, H; Fellstrom, B; Holme, I; Nyberg, G; Fauchald, P; Jardine, A; Gronhagen-Riska, C; Madser, S; Neumayer, HH; Cole, E; Maes, B; Weinreich, T; Olsson, AG; Pedersen, TR; Benghozi, R; Hartmann, A
    Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol (R) in Renal Transplantation) study design and baseline data
    JOURNAL OF CARDIOVASCULAR RISK
    
    H. Holdaas et al., "Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol (R) in Renal Transplantation) study design and baseline data", J CARD RISK, 8(2), 2001, pp. 63-71
70. Aihara, Y; Katakura, S; Imagawa, T; Mitsuda, T; Yokota, S
    Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy
    PEDIATRICS INTERNATIONAL
    
    Y. Aihara et al., "Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy", PEDIATR INT, 43(1), 2001, pp. 95-97
71. Bastani, B; Mistry, BM; Jamal, JA; Contis, J
    Cyclosporine-associated post-partum haemolytic uraemic syndrome in a renaltransplant patient: lack of response to plasmapheresis but remission afterintravenous immunoglobulin G
    NEPHROLOGY
    
    B. Bastani et al., "Cyclosporine-associated post-partum haemolytic uraemic syndrome in a renaltransplant patient: lack of response to plasmapheresis but remission afterintravenous immunoglobulin G", NEPHROLOGY, 6(3), 2001, pp. 133-137
72. Korbet, SM; Schwartz, MM
    Primary focal segmental glomerulosclerosis: a treatable lesion with variable outcomes
    NEPHROLOGY
    
    S.M. Korbet e M.M. Schwartz, "Primary focal segmental glomerulosclerosis: a treatable lesion with variable outcomes", NEPHROLOGY, 6(2), 2001, pp. 47-56
73. Legendre, C; Thervet, E; Bedrossian, J
    New immunosuppressive drugs and diabetes mellitus.
    DIABETES & METABOLISM
    
    C. Legendre et al., "New immunosuppressive drugs and diabetes mellitus.", DIABETE MET, 27(2), 2001, pp. 172-176
74. Garrood, T; Scott, DL
    Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    BIODRUGS
    
    T. Garrood e D.L. Scott, "Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis", BIODRUGS, 15(8), 2001, pp. 543-561
75. Fellstrom, B
    Risk factors for and management of post-transplantation cardiovascular disease
    BIODRUGS
    
    B. Fellstrom, "Risk factors for and management of post-transplantation cardiovascular disease", BIODRUGS, 15(4), 2001, pp. 261-278
76. Hatton, J
    Pharmacological treatment of traumatic brain injury - A review of agents in development
    CNS DRUGS
    
    J. Hatton, "Pharmacological treatment of traumatic brain injury - A review of agents in development", CNS DRUGS, 15(7), 2001, pp. 553-581
77. Meier-Kriesche, HU; Kaplan, B
    Immunosuppression in elderly renal transplant recipients - Are current regimens too aggressive?
    DRUGS & AGING
    
    H.U. Meier-Kriesche e B. Kaplan, "Immunosuppression in elderly renal transplant recipients - Are current regimens too aggressive?", DRUG AGING, 18(10), 2001, pp. 751-759
78. Freyschmidt-Paul, P; Ziegler, A; McElwee, KJ; Happle, R; Kissling, S; Sundberg, JP; Hoffmann, R
    Treatment of alopecia areata in C3H/Hej mice with the topical immunosuppressant FK506 (Tacrolimus)
    EUROPEAN JOURNAL OF DERMATOLOGY
    
    P. Freyschmidt-Paul et al., "Treatment of alopecia areata in C3H/Hej mice with the topical immunosuppressant FK506 (Tacrolimus)", EUR J DERM, 11(5), 2001, pp. 405-409
79. Piastra, M; Pulitano, S; Chiaretti, A; Polidori, G
    Transient hemiplegia and seizures in an 18-month-old child following livertransplantation
    PAEDIATRIC ANAESTHESIA
    
    M. Piastra et al., "Transient hemiplegia and seizures in an 18-month-old child following livertransplantation", PAEDIATR AN, 11(3), 2001, pp. 377-378
80. Abbott, KC; Hypolite, IO; Hshieh, P; Cruess, D; Agodoa, LYC; Welch, PG; Taylor, AJ; Yuan, CM
    The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes
    JOURNAL OF NEPHROLOGY
    
    K.C. Abbott et al., "The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes", J NEPHROL, 14(5), 2001, pp. 369-376
81. Zerbi, S; Saruggia, M; Brambilla, L; Lodeville, D; Buccianti, G
    Kaposi's sarcoma in a patient with focal glomerulosclerosis
    JOURNAL OF NEPHROLOGY
    
    S. Zerbi et al., "Kaposi's sarcoma in a patient with focal glomerulosclerosis", J NEPHROL, 14(4), 2001, pp. 299-303
82. Seron, D; Moreso, F; Grinyo, JM
    Prevention and management of late renal allograft dysfunction
    JOURNAL OF NEPHROLOGY
    
    D. Seron et al., "Prevention and management of late renal allograft dysfunction", J NEPHROL, 14(2), 2001, pp. 71-79
83. Figueroa, MS; Ciancas, E; Mompean, B; Quereda, C
    Treatment of multiple evanescent white dot syndrome with cyclosporine
    EUROPEAN JOURNAL OF OPHTHALMOLOGY
    
    M.S. Figueroa et al., "Treatment of multiple evanescent white dot syndrome with cyclosporine", EUR J OPTHA, 11(1), 2001, pp. 86-88
84. Kamm, MA
    New therapeutic possibilities in inflammatory bowel disease
    EUROPEAN JOURNAL OF SURGERY
    
    M.A. Kamm, "New therapeutic possibilities in inflammatory bowel disease", EURO J SURG, 167, 2001, pp. 30-33
85. Sturzenbaum, SR; Kille, P
    Control genes in quantitative molecular biological techniques: the variability of invariance
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    
    S.R. Sturzenbaum e P. Kille, "Control genes in quantitative molecular biological techniques: the variability of invariance", COMP BIOC B, 130(3), 2001, pp. 281-289
86. Kashiwagi, A; Kanno, T; Arita, K; Ishisaka, R; Utsumi, T; Utsumi, K
    Suppression of T-3- and fatty acid-induced membrane permeability transition by L-carnitine
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    
    A. Kashiwagi et al., "Suppression of T-3- and fatty acid-induced membrane permeability transition by L-carnitine", COMP BIOC B, 130(3), 2001, pp. 411-418
87. Dykewicz, MS
    Newer and alternative non-steroidal treatments for asthmatic inflammation
    ALLERGY AND ASTHMA PROCEEDINGS
    
    M.S. Dykewicz, "Newer and alternative non-steroidal treatments for asthmatic inflammation", ALL ASTH P, 22(1), 2001, pp. 11-15
88. Ballinger, JR
    Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    J.R. Ballinger, "Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein", CANC BIO R, 16(1), 2001, pp. 1-7
89. Grumet, FC; Hiraki, DD; Brown, BW; Zehnder, JL; Zacks, ES; Draksharapu, A; Parnes, J; Negrin, RS
    CD31 mismatching affects marrow transplantation outcome
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    F.C. Grumet et al., "CD31 mismatching affects marrow transplantation outcome", BIOL BLOOD, 7(9), 2001, pp. 503-512
90. Khan, SA; Gaa, B; Pollock, BH; Shea, B; Reddy, V; Wingard, YR; Moreb, JS
    Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    S.A. Khan et al., "Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival", BIOL BLOOD, 7(8), 2001, pp. 433-438
91. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
    Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    H. Khoury et al., "Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen", BIOL BLOOD, 7(6), 2001, pp. 352-358
92. Stern, JM; Sullivan, KM; Ott, SM; Seidel, K; Fink, JC; Longton, G; Sherrard, DF
    Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    J.M. Stern et al., "Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study", BIOL BLOOD, 7(5), 2001, pp. 257-264
93. Deeg, HJ; Amylon, MD; Harris, RE; Collins, R; Beatty, PG; Feig, S; Ramsay, N; Territo, M; Khan, SP; Pamphilon, D; Leis, JF; Burdach, S; Anasetti, C; Hackman, R; Storer, B; Mueller, B
    Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    H.J. Deeg et al., "Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation", BIOL BLOOD, 7(4), 2001, pp. 208-215
94. Anderson, JE; Appelbaum, FR; Schoch, G; Barnett, T; Chauncey, TR; Flowers, MED; Storb, R
    Relapse alter allogeneic bone marrow transplantation for refractory anemiais increased by shielding lungs and liver during total body irradiation
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    J.E. Anderson et al., "Relapse alter allogeneic bone marrow transplantation for refractory anemiais increased by shielding lungs and liver during total body irradiation", BIOL BLOOD, 7(3), 2001, pp. 163-170
95. Matsuo, N; Shimoda, T; Mitsuta, K; Fukushima, C; Matsuse, H; Obase, Y; Kohno, S
    Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    N. Matsuo et al., "Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues", ANN ALLER A, 86(6), 2001, pp. 671-678
96. Kulkarni, P
    Review: Uveitis and immunosuppressive drugs
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    
    P. Kulkarni, "Review: Uveitis and immunosuppressive drugs", J OCUL PH T, 17(2), 2001, pp. 181-187
97. Matsui, K; Tanaka, N; Nishikawa, A
    Lipopolysaccharide of Haemophilus influenzae induces interleukin-5 mRNA expression in human peripheral blood mononuclear cells
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    K. Matsui et al., "Lipopolysaccharide of Haemophilus influenzae induces interleukin-5 mRNA expression in human peripheral blood mononuclear cells", J INTERF CY, 21(6), 2001, pp. 439-443
98. Porter, CJH; Charman, WN
    Lipid-based formulations for oral administration: Opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs (Reprinted from Drug Targeting Technology: Physical - Chemical - Biological Methods - Drugs and the Pharmaceutical Sciences, vol 115, pg 85-130, 2001)
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    
    C.J.H. Porter e W.N. Charman, "Lipid-based formulations for oral administration: Opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs (Reprinted from Drug Targeting Technology: Physical - Chemical - Biological Methods - Drugs and the Pharmaceutical Sciences, vol 115, pg 85-130, 2001)", J RECEPT SI, 21(2-3), 2001, pp. 215-257
99. Andriambeloson, E; Bigaud, M; Schraa, EO; Kobel, T; Lobstein, V; Pally, C; Zerwes, HG
    Endothelial dysfunction and denudation in rat aortic allografts
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    E. Andriambeloson et al., "Endothelial dysfunction and denudation in rat aortic allografts", ART THROM V, 21(1), 2001, pp. 67-73
100. Hernandez, G; Jimenez, C; Arriba, L; Moreno, E; Lucas, M
     Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient
     ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
     
     G. Hernandez et al., "Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient", ORAL SURG O, 92(5), 2001, pp. 526-531